Another study conducted by GSK demonstrated about 462,795 (cathepsin inhibitor which can be administered orally) and is used for the treatment of postmenopausal osteoarthritis, rheumatoid arthritis and osteoporosis (http://www.gsk.com). The gene discussed is CTSS; the disease is osteoporosis.